Abstract
Stroke represents the third most common cause of death and is a major reason for hospitalization in the developed countries. It afflicts approximately 700000 Europeans annually. Stroke is a tragic occurrence to its victims and it also causes enormous financial costs. To date, no therapy is available to improve the outcome of patients with ischemic stroke. Stroke therapies have been aimed at the prevention of future cerebrovascular attacks. The significant mortality and morbidity associated with stroke necessitate development of acute therapeutic interventions to limit stroke mortality and morbidity.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
del Zoppo GJ, Ferbert A, Otis S, et al (1988) Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. Stroke 19:307–313
Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19:1216–1222
Mahoney FI, Barthel DW (1965) Functional evaluation: The Barthel Index. Maryland State Med 14:61–65
Mori E, Tabuchi M, Yoshida T, Yamador A (1988) Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19:802–812
Peto R, Pike MC, Armitage P, et al (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 34:585–612
Scandinavian Stroke Study Group (1985) Multicenter trial of hemodilution in ischemic stroke — background and study protocol. Stroke 16:885–890
The TIMI Study Group (1989) Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 320:618–627
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kaste, M., Fieschi, C., Hacke, W., Lesaffre, E., Verstraete, M., Fröhlich, J. (1993). The European Cooperative Acute Stroke Study (ECASS). In: del Zoppo, G.J., Mori, E., Hacke, W. (eds) Thrombolytic Therapy in Acute Ischemic Stroke II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78061-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-78061-5_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56442-3
Online ISBN: 978-3-642-78061-5
eBook Packages: Springer Book Archive